Chiara Herzog discusses clinical translation of biomarkers of aging, touching on her work in Austria and the work of the Biomarkers of Aging Consortium's Longevity Study, partnered with Harvard Medical School.

Timestamps
[00:00:47] Cardiovascular disease as a useful model for surrogate endpoint development for aging
[00:01:25] Outstanding barriers for biomarkers of aging
[00:03:06] Human intervention studies in Austria to implement standards for preventative studies
[00:06:44] The lifestyle access is a systematic longitudinal multi-omic and clinical profiling over the course of human-extending lifestyle intervention
[00:07:24] The Longevity Study of the Biomarkers of Aging Consortium

Dr. Chiara Herzog is a researcher at University of Innsbruck, co-PI of a large human multi-omic geroprevention study, and member of the Biomarkers of Aging Consortium Executive Committee. Her interests lie in the successful application of aging biomarkers for human interventions and risk stratification. Learn more about The Longevity Study at [ Ссылка ]

свернуть